Netherlands - Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes and Compulsory Contributory Health Care Financing Schemes
Since 2014, Netherlands Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes and Compulsory Contributory Health Care Financing Schemes increased 0.7% year on year. In 2019, the country was number 15 among other countries in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes and Compulsory Contributory Health Care Financing Schemes with €224.53 Per Capita. Netherlands is overtaken by Spain, which was number 14 at €243.23 Per Capita and is followed by Iceland with €208.16 Per Capita. Switzerland ranked the highest with €666.37 Per Capita in 2019, that is +3.2% versus 2018. Germany, Liechtenstein and Ireland respectively ranked number 2, 3 and 4 in this ranking. Latvia recorded the best 5 years average growth at +8.8% per year, while Romania was the worst growing country at -1.7% per year.
Loading...
| Date | Euros Per Capita |
|---|---|
| 2019 | 224.53 |
| 2018 | 225.98 |
| 2017 | 224.27 |
| 2016 | 223.95 |
| 2015 | 220.96 |
How does Netherlands rank in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes and Compulsory Contributory Health Care Financing Schemes?
| # | 33 Countries | Euros Per Capita | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Switzerland
|
666.37 | 2019 | +3.1 % | +5.3 % | View data | |
| 2 |
#2
Germany
|
553.39 | 2019 | +2.3 % | +3.0 % | View data | |
| 14 |
#14
Spain
|
243.23 | 2019 | -1.1 % | +1.7 % | View data | |
| 15 |
#15
Netherlands
|
224.53 | 2019 | -0.6 % | +0.7 % | View data | |
| 16 |
#16
Iceland
|
208.16 | 2019 | +0.2 % | +4.1 % | View data | |